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Introduction
microbial drugs [2] . Despite the basic similarity in the core structure of these molecules, their physiochemical Non-steroidal anti-inflammatory drugs (NSAIDs) properties, pharmacokinetic characteristics, and antiare widely used drugs in both veterinary and human microbial activities vary markedly across compounds medicine for various inflammatory conditions of [3] . Levofloxacin, the active L-isomer of the racemate infectious or non-infectious origin [1] . NSAIDs act by ofloxacin, has nearly 100% oral bioavailability and is inhibiting the pro-prostaglandin enzymes, cyclooxythus preferred over FQs that have broad spectrum of genase-2 (COX-2), and cyclooxygenase-1(COX-1).
activities, but limited oral bioavailability [4] . It is used The COX-2 inhibition is considered to mediate the alone or in combination with other antibacterial drugs therapeutic actions of NSAIDs, while the COX-1 to treat certain bacterial infections, including inhibition usually results in unwanted side-effects, pneumonia, urinary tract infections, and abdominal particularly in the gastrointestinal tract [1] . Meloxicam infections. Pazufloxacin, a fused tricyclic quinolone, is a NSAID that has an apparently greater selectivity has a 1-aminocyclopropyl substituent at C-10 position, towards inhibition of inducible COX-2 isoform, than a unique feature of the molecule contributing the potent the constitutive isoform COX-1 [1] .
broad spectrum activity to this drug [5] . It may be used Fluoroquinolones (FQs) are the quinolones with as the drug of choice in community acquired infections, fluorine atom attached to the central ring system, acute exacerbation of chronic bronchitis and posttypically at the C-6 position or C-7 position. These are abdominal infection sepsis [6] . Enrofloxacin, a 6-bactericidal drugs that inhibit the bacterial enzymes fluoro-7-piperazinyl-4-quinolone approved for DNA gyrase and topoisomerase IV and possess a broad veterinary use, has been evaluated as a method to spectrum of anti-bacterial activity against a range of eliminate Salmonella infections in cattle and poultry bacteria, including the ones resistant to other antiand manage several bacterial diseases in lagomorphs, from Pasteurella multocida to Mycoplasma spp. [7] . Oral dosing with enrofloxacin does not appear to develop antibiotic dysbiosis, which is common with penicillins and cephalosporins [7] . kept under normal ambient conditions, with an average Although fluoroquinolones (FQs) are relatively day length of 11.5 hours, in a well-lighted experimental safer drugs, certain adverse effects such as gastrohouse. The animals were maintained on standard rabbit intestinal discomfort, hepatotoxic reactions, central feed and ad libitum water. nervous system effects, juvenile joint toxicity, The drugs used in the fluids [19] . It could be used to assess the real change in study are for information purpose only. Authors or antioxidant status in patients with severe infection and institute of authors do not recommend the use of these can thus make the treatment effective [20] . Complicated drugs. infections require weeks of antibiotic therapy and Plasma antioxidant activity analysis: Blood samples protracted course of NSAIDs to manage various were collected from the ear vein of these animals in associated inflammatory conditions like pyrexia and heparinized vials on 0, 7, 14 and 21 day of treatment. pain [21, 22] . Taking the above facts into consideration
The plasma AOA was determined by the method of and the lack of sufficient toxicological data regarding Koracevic et al. [28] based on the principle that a the simultaneous exposure of FQs and NSAIDs, we standardized solution of Fe-EDTA complex reacts with evaluated meloxicam, levo-floxacin, pazufloxacin and hydrogen peroxide by a Fenton-type reaction, leading enrofloxacin for their effect on the plasma AOA that to the formation of hydroxyl radicals that degrade could give some insight of their basic toxicological benzoate, resulting in the release of thio-barbituric acid profile. Since prolonged treatment of some drugs reactive substances (TBARS). Antioxidants from the (zonisamide, topiramate, caffeine, etc) leads to body added plasma suppress TBARS production. This weight loss, drugs like antipsycotics, on the other hand, reaction was measured spectrophotometrically and the produce obesity in humans [23, 24] . The assessment of inhibition of color development is defined as the total body weight parameter would indicate general impact antioxidant activity. on metabolism in addition to generating data regarding the above cited effects of drugs on the body weight.
Body weight: Body weight was determined with an This will also help in considering dosage corrections of electronic weighing balance at 0, 7, 14 and 21 days of these drugs when used for prolonged durations.
treatment. These weekly body weight values were also The availability of data on body weight with the used to make the necessary corrections in dose of the co-administration of NSAIDs and FQs is also lacking.
above drugs administered. The weekly determined Thus, we also evaluated the effect of these drugs on body weight of each animal was expressed as the body weight and correlated the body weight with AOA percentage of its zero day body weight to determine the to determine any relation between the two parameters.
trend in the body weight pattern.
Materials and Methods
Statistical analysis: All these results were subjected to analysis of variance carried in completely randomized Animals: Thirty two male adult Soviet Chinchilla design, and the significance was tested using Duncan's rabbits of 6 months of age, weighing around 3 Kg, were multiple range test [29] . The results for AOA were of small number of electrons to oxygen forms reactive correlated with body weight with Pearson's correlation.
oxygen species (ROS) [35] . The biological outcome of The significance was assayed at 5 % (p<0.05) levels.
mitochondrial ROS production and its potential These statistical calculations were carried out with involvement in physiological (signal transduction) SPSS 16.0 software.
versus pathological processes (oxidative stress induced disorders) depends on the balance between
Results and Discussion
their production and detoxification [36] . Plasma AOA The results for the effect of meloxicam, levofloxacin, includes both enzymatic and nonenzymatic antioxidant pazufloxacin and enrofloxacin on the plasma systems [37], the measurement of which provides a antioxidative activity in rabbits are presented in the holistic picture of antioxidant status than the 21 day of treatment when all treated groups, except on the concurrent exposure of FQs and NSAIDs.
group C, had significantly lower levels of AOA Elimination of xenobiotic requires ATP as the compared to the control group. energy source. During the ATP synthesis from mito-
The results for the effect of meloxicam and the chondrial electron transport chain, a premature leakage Values given are mean ± standard error of mean for 4 animals Means, in a column, with different superscript do not differ significantly Values given are mean ± standard error of mean for 4 animals Means, in a column, with one common superscript do not differ significantly
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above FQs on body weight are presented in Table- indicates that the predisposition to the pathological 
